CRESCENT BIOPHARMA, INC. Public Float
CRESCENT BIOPHARMA, INC. (CBIO) had Public Float of $177.20 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $177.20M.
- 2024-06-30: Entity Public Float $17.50M.
- 2023-06-30: Entity Public Float $109.30M.
- 2022-06-30: Entity Public Float $30.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $177.20M 10-K · filed 2026-02-26 |
| 2024-06-30 | $17.50M 10-K · filed 2025-02-13 |
| 2023-06-30 | $109.30M 10-K · filed 2024-03-27 |
| 2022-06-30 | $30.90M 10-K · filed 2023-03-29 |
| 2021-06-30 | $117.50M 10-K · filed 2022-03-03 |
| 2020-06-30 | $137.80M 10-K · filed 2021-03-02 |
| 2019-06-28 | $399.50M 10-K · filed 2020-02-28 |
| 2018-06-30 | $538.30M 10-K · filed 2019-03-06 |
| 2017-06-30 | $262.50M 10-K · filed 2018-03-06 |
| 2016-06-30 | $100.40M 10-K · filed 2017-03-01 |
| 2015-06-30 | $77.90M 10-K · filed 2016-02-29 |
| 2014-06-30 | $79.10M 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |